{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:14:48Z","timestamp":1792034088898,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2021,2,15]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Opioid prescriptions and abuse remain a significant national concern. Cannabinoids offer a potentially attractive nonopioid analgesic option for orthopaedic patients, and 32 US states have passed medical cannabis laws (MCLs), legalizing patient access to cannabinoids. We examine the association between implementation of state cannabis laws and prescribing patterns for opioids by orthopaedic surgeons in Medicare Part D patients between 2013 and 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using the Medicare Part D Prescription Drug Event database, we measured annual aggregate daily doses of all opioid medications (excluding buprenorphine) prescribed by orthopaedic surgeons in each US state (and DC), in addition to total daily doses of opioid medications by generic name (hydrocodone, oxycodone, fentanyl, morphine, methadone, and \u201cother opioids\u201d). We used adjusted linear regression models to examine associations between state-specific cannabis regulations (state MCL, MCL type\u2014dispensary or home cultivation, and recreational cannabis legalization) and annual total daily doses of opioid medications (all opioids and opioid types, separately).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      State MCLs were associated with a statistically significant reduction in aggregate opioid prescribing of 144,000 daily doses (19.7% reduction) annually (95% confidence interval [CI], \u22120.535 to \u22120.024 million;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). States with MCLs allowing access to in-state dispensaries had a statistically significant reduction in total opioid prescriptions of 96,000 daily doses (13.1%) annually (95% CI, \u22120.165 to \u22120.026 million;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Specifically, MCLs were associated with a statistically significant reduction of 72,000 daily doses of hydrocodone annually (95% CI, \u22120.164 to \u22120.019 million;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). No significant association between recreational marijuana legalization and opioid prescribing was found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Orthopaedic surgeons are among the highest prescribers of opioids, highlighting the importance of providing nonopioid analgesic alternatives in efforts to reduce opioid use in the patient cohort. This study is the first to examine the association between implementation of state cannabis laws and prescribing patterns for opioids by orthopaedic surgeons in Medicare Part D patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Population-based ecological study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-19-00767","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:14:37Z","timestamp":1589289277000},"page":"e188-e197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort"],"prefix":"10.5435","volume":"29","author":[{"given":"Cesar D.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Boddapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Jobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-8487","authenticated-orcid":false,"given":"Thomas R.","family":"Hickernell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016","volume":"319","author":"Jones","year":"2018","journal-title":"JAMA"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","article-title":"Cannabinoids and pain: Sites and mechanisms of action","volume":"80","author":"Starowicz","year":"2017","journal-title":"Adv Pharmacol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.2016.13677","article-title":"Opioids out, cannabis in: Negotiating the unknowns in patient care for chronic pain","volume":"316","author":"Choo","year":"2016","journal-title":"JAMA"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1126\/science.354.6312.566","article-title":"Pot and pain","volume":"354","author":"Miller","year":"2016","journal-title":"Science"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","article-title":"Cannabinoids for the treatment of chronic non-cancer pain: An updated systematic review of randomized controlled trials","volume":"10","author":"Lynch","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jpain.2016.02.007","article-title":"Cannabis in pain treatment: Clinical and research considerations","volume":"17","author":"Savage","year":"2016","journal-title":"J Pain"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: A randomized controlled trial","volume":"182","author":"Ware","year":"2010","journal-title":"CMAJ"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J Pain"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-clinpsy-032816-045128","article-title":"Medical marijuana and marijuana legalization","volume":"13","author":"Pacula","year":"2017","journal-title":"Annu Rev Clin Psychol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5435\/JAAOS-D-14-00163","article-title":"The opioid epidemic: Impact on orthopaedic surgery","volume":"23","author":"Morris","year":"2015","journal-title":"J Am Acad Orthop Surg"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jamainternmed.2018.1007","article-title":"Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees","volume":"178","author":"Wen","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jamainternmed.2018.0266","article-title":"Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population","volume":"178","author":"Bradford","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1377\/hlthaff.2015.1661","article-title":"Medical marijuana laws reduce prescription medication use in Medicare Part D","volume":"35","author":"Bradford","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1377\/hlthaff.2016.1135","article-title":"Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees","volume":"36","author":"Bradford","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","article-title":"Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients","volume":"42","author":"Lucas","year":"2017","journal-title":"Int J Drug Policy"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/02791072.2012.684624","article-title":"Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain","volume":"44","author":"Lucas","year":"2012","journal-title":"J Psychoactive Drugs"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s10194-018-0862-2","article-title":"Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort","volume":"19","author":"Baron","year":"2018","journal-title":"J Headache Pain"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7517-6-35","article-title":"Cannabis as a substitute for alcohol and other drugs","volume":"6","author":"Reiman","year":"2009","journal-title":"Harm Reduct J"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1073\/pnas.1903434116","article-title":"Association between medical cannabis laws and opioid overdose mortality has reversed over time","volume":"116","author":"Shover","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1176\/appi.ajp.2017.17040413","article-title":"Cannabis use and risk of prescription opioid use disorder in the United States","volume":"175","author":"Olfson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2018.09.016","article-title":"Recreational marijuana legalization and prescription opioids received by Medicaid enrollees","volume":"194","author":"Shi","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/add.14382","article-title":"Medical cannabis legalization and opioid prescriptions: Evidence on US Medicaid enrollees during 1993-2014","volume":"113","author":"Liang","year":"2018","journal-title":"Addiction"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain: United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","article-title":"Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians","volume":"35","author":"Bao","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/003335491412900207","article-title":"Prescription drug monitoring and dispensing of prescription opioids","volume":"129","author":"Brady","year":"2014","journal-title":"Public Health Rep"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1016\/j.arth.2018.07.027","article-title":"Should cannabinoids be added to multimodal pain regimens after total hip and knee arthroplasty?","volume":"33","author":"Hickernell","year":"2018","journal-title":"J Arthroplasty"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.arth.2019.04.015","article-title":"Cannabis use does not affect outcomes after total knee arthroplasty","volume":"34","author":"Jennings","year":"2019","journal-title":"J Arthroplasty"},{"key":"R32-20250503","first-page":"268","article-title":"Change in prescription habits after federal rescheduling of hydrocodone combination products","volume":"29","author":"Seago","year":"2016","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-19-00767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:40:08Z","timestamp":1787668808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-19-00767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-19-00767","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"2019-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}